董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Lee A. Shapiro | 男 | Director | 61 | 29.16万美元 | 未持股 | 2017-04-19 |
| Tarek A. Sherif | 男 | Chairman, Chief Executive Officer and Director | 54 | 793.10万美元 | 未持股 | 2017-04-19 |
| Glen M. de Vries | 男 | President and Director | 44 | 792.74万美元 | 未持股 | 2017-04-19 |
| Carlos Dominguez | 男 | Director | 58 | 28.70万美元 | 未持股 | 2017-04-19 |
| Neil M. Kurtz | 男 | Director | 66 | 30.14万美元 | 未持股 | 2017-04-19 |
| George W. McCulloch | 男 | Director | 40 | 29.46万美元 | 未持股 | 2017-04-19 |
| Robert B. Taylor | 男 | Director | 69 | 33.04万美元 | 未持股 | 2017-04-19 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mary Weger | 女 | Executive Vice President-Human Resources | 58 | 未披露 | 未持股 | 2017-04-19 |
| Rouven Bergmann | 男 | Chief Financial Officer | 44 | 321.95万美元 | 未持股 | 2017-04-19 |
| Michael Pray | 男 | Executive Vice President-General Manager of Global Sales | 51 | 未披露 | 未持股 | 2017-04-19 |
| Michael L. Capone | 男 | Chief Operating Officer | 50 | 490.92万美元 | 未持股 | 2017-04-19 |
| Tarek A. Sherif | 男 | Chairman, Chief Executive Officer and Director | 54 | 793.10万美元 | 未持股 | 2017-04-19 |
| Glen M. de Vries | 男 | President and Director | 44 | 792.74万美元 | 未持股 | 2017-04-19 |
| Michael I. Otner | 男 | Executive Vice President-General Counsel and Corporate Secretary | 46 | 157.56万美元 | 未持股 | 2017-04-19 |
董事简历
中英对照 |  中文 |  英文- Lee A. Shapiro
-
Lee A. Shapiro,2002年成为Allscripts的总裁;2000年加入Allscripts。他指导着本公司的战略举措,其中包括最近完成的与Eclipsys and Misys的交易、之前与 Misys Healthcare的合并,以及本公司Physician’s Interactive and Medication Solutions Group的出售。他还在A4 Health Systems、ChannelHealth Incorporated、Advanced Imaging Concepts、RxCentric的收购业务中,发挥了重要的作用。加入Allscripts之前,他是Douglas Elliman-Beitler的首席运营官,这是商业写字楼管理与开发公司,管理着该公司的美国业务。之前,他担任SES Properties的总裁,这是密集持股、完全整合的房地产公司,位于加州Carlsbad。同期,他成立了City Financial Bancorp,并担任其副董事长,负责金融机构的收购、融资、监管事务、法律事务、业务审核与重组,以及最终的出售。他还曾在芝加哥的律师事务所Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg从事过商业法律执业。他目前是Medidata Solutions、Perseus Acquisition LLC Physicians Interactive的董事,以及Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University的成员。他还是Gastro-Intestinal Research Foundation的官员、董事。2009-2010,他曾被任命为Economic Recovery Commission of the State of Illinois的成员。
Lee A. Shapiro is currently managing partner and co-founder of 7wire Ventures, a private investment firm that seeks and invests in innovative ideas and entrepreneurs mostly in the areas of healthcare and education. Previously, Mr. Shapiro was president of Allscripts Healthcare Solutions, Inc., a provider of innovative technology solutions, from 2002 to December 2012 where he oversaw the company’s strategy, international operations, health plan initiatives and entrepreneurial business investments, and was a consultant to Allscripts from December 2012 to June 2013. Prior to joining Allscripts, he was the chief operating officer of Douglas Elliman-Beitler, a commercial office management and development company, where he directed all business activities throughout the United States. Mr. Shapiro’s career also includes serving as president of SES Properties, Inc., vice chairman of City Financial Bancorp and practicing commercial law at Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg. Mr. Shapiro was also appointed to the Economic Recovery Commission of the State of Illinois during its seating in 2009-2010. He currently serves on the board of directors of Tivity Health, Inc. f/k/a Healthways, Inc., the largest independent global provider of well-being improvement solutions (where he is chair of the audit committee), and Aptus Health (f/k/a Physicians Interactive Holdings), a subsidiary of Merck. Mr. Shapiro holds a J.D. degree from The University of Chicago Law School and a B.S. in Accounting from the University of Illinois Urbana-Champaign. - Lee A. Shapiro,2002年成为Allscripts的总裁;2000年加入Allscripts。他指导着本公司的战略举措,其中包括最近完成的与Eclipsys and Misys的交易、之前与 Misys Healthcare的合并,以及本公司Physician’s Interactive and Medication Solutions Group的出售。他还在A4 Health Systems、ChannelHealth Incorporated、Advanced Imaging Concepts、RxCentric的收购业务中,发挥了重要的作用。加入Allscripts之前,他是Douglas Elliman-Beitler的首席运营官,这是商业写字楼管理与开发公司,管理着该公司的美国业务。之前,他担任SES Properties的总裁,这是密集持股、完全整合的房地产公司,位于加州Carlsbad。同期,他成立了City Financial Bancorp,并担任其副董事长,负责金融机构的收购、融资、监管事务、法律事务、业务审核与重组,以及最终的出售。他还曾在芝加哥的律师事务所Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg从事过商业法律执业。他目前是Medidata Solutions、Perseus Acquisition LLC Physicians Interactive的董事,以及Kellogg Innovation Network Advisory Board of the Kellogg School of Management, Northwestern University的成员。他还是Gastro-Intestinal Research Foundation的官员、董事。2009-2010,他曾被任命为Economic Recovery Commission of the State of Illinois的成员。
- Lee A. Shapiro is currently managing partner and co-founder of 7wire Ventures, a private investment firm that seeks and invests in innovative ideas and entrepreneurs mostly in the areas of healthcare and education. Previously, Mr. Shapiro was president of Allscripts Healthcare Solutions, Inc., a provider of innovative technology solutions, from 2002 to December 2012 where he oversaw the company’s strategy, international operations, health plan initiatives and entrepreneurial business investments, and was a consultant to Allscripts from December 2012 to June 2013. Prior to joining Allscripts, he was the chief operating officer of Douglas Elliman-Beitler, a commercial office management and development company, where he directed all business activities throughout the United States. Mr. Shapiro’s career also includes serving as president of SES Properties, Inc., vice chairman of City Financial Bancorp and practicing commercial law at Barack, Ferrazzano, Kirschbaum, Perlman & Nagelberg. Mr. Shapiro was also appointed to the Economic Recovery Commission of the State of Illinois during its seating in 2009-2010. He currently serves on the board of directors of Tivity Health, Inc. f/k/a Healthways, Inc., the largest independent global provider of well-being improvement solutions (where he is chair of the audit committee), and Aptus Health (f/k/a Physicians Interactive Holdings), a subsidiary of Merck. Mr. Shapiro holds a J.D. degree from The University of Chicago Law School and a B.S. in Accounting from the University of Illinois Urbana-Champaign.
- Tarek A. Sherif
-
Tarek A. Sherif,是公司创立者之一。从2001年开始,他担任首席执行官,从2000年开始他担任公司董事。在成立Medidata 公司之前,他是Sherif Partners 公司管理人员,这是一家专注于科技和生命科学公司公开或私募投资的公司。在那之前,他在R.D.L. Securities公司担任投资组合经理,这是一家私人股本基金公司,主要专注于上市公司,包括哪些健康保健和信息科技领域的公司。他也在通用电气资本公司(General Electric Capital Corporation)担任财务助理副总裁,在Brown Brothers Harriman & Company公司担任合并和收购分析师。他在耶鲁大学(Yale College)得到经济学学士学位,在哥伦比亚大学(Columbia University)得到企业行政和财务工商管理硕士学位。
Tarek A. Sherif is one of our founders. Mr. Sherif has served as our chief executive officer since 2001 and as a member of our board of directors since 2000. Prior to forming Medidata, Mr. Sherif co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance. Mr. Sherif holds a B.A. in economics from Yale College and an M.B.A. in business administration and finance from Columbia University. - Tarek A. Sherif,是公司创立者之一。从2001年开始,他担任首席执行官,从2000年开始他担任公司董事。在成立Medidata 公司之前,他是Sherif Partners 公司管理人员,这是一家专注于科技和生命科学公司公开或私募投资的公司。在那之前,他在R.D.L. Securities公司担任投资组合经理,这是一家私人股本基金公司,主要专注于上市公司,包括哪些健康保健和信息科技领域的公司。他也在通用电气资本公司(General Electric Capital Corporation)担任财务助理副总裁,在Brown Brothers Harriman & Company公司担任合并和收购分析师。他在耶鲁大学(Yale College)得到经济学学士学位,在哥伦比亚大学(Columbia University)得到企业行政和财务工商管理硕士学位。
- Tarek A. Sherif is one of our founders. Mr. Sherif has served as our chief executive officer since 2001 and as a member of our board of directors since 2000. Prior to forming Medidata, Mr. Sherif co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance. Mr. Sherif holds a B.A. in economics from Yale College and an M.B.A. in business administration and finance from Columbia University.
- Glen M. de Vries
-
Glen M. de Vries ,是公司创立者之一。从2008年2月开始,他担任公司总裁,从1999年开始,他担任公司董事。从2000年到2008年,他担任公司首席科技官。他在医疗软件开发方面有超过15年的经验,包括电子健康记录和以消费者为导向的产品方面。作为OceanTek公司的总裁,这是一家专注于健康保健业应用的网络开发公司,他是全球财富500强电子商务项目首席咨询师,目前也是网站和企业内部网使用的网络安全组件的制作者。之前,他在哥伦比亚大学(Columbia University)担任研究助理,专注于研究科学和创造无纸化临床数据管理系统。他在卡内基梅隆大学(Carnegie Mellon University)得到分子生物学和遗传学学士学位。
Glen M. de Vriesis one of our founders. Mr. de Vries has served as our president since February 2008 and as a member of our board of directors since 1999. From 2000 to 2008 Mr. de Vries served as our chief technology officer. Mr. de Vries has over 20 years of experience in medical software development, including electronic health records and consumer-targeted products. Previously, he served as a research assistant at Columbia University focusing on both research science and creating a paperless clinical data management system. Mr. de Vries holds a B.S. in molecular biology and genetics from Carnegie Mellon University. - Glen M. de Vries ,是公司创立者之一。从2008年2月开始,他担任公司总裁,从1999年开始,他担任公司董事。从2000年到2008年,他担任公司首席科技官。他在医疗软件开发方面有超过15年的经验,包括电子健康记录和以消费者为导向的产品方面。作为OceanTek公司的总裁,这是一家专注于健康保健业应用的网络开发公司,他是全球财富500强电子商务项目首席咨询师,目前也是网站和企业内部网使用的网络安全组件的制作者。之前,他在哥伦比亚大学(Columbia University)担任研究助理,专注于研究科学和创造无纸化临床数据管理系统。他在卡内基梅隆大学(Carnegie Mellon University)得到分子生物学和遗传学学士学位。
- Glen M. de Vriesis one of our founders. Mr. de Vries has served as our president since February 2008 and as a member of our board of directors since 1999. From 2000 to 2008 Mr. de Vries served as our chief technology officer. Mr. de Vries has over 20 years of experience in medical software development, including electronic health records and consumer-targeted products. Previously, he served as a research assistant at Columbia University focusing on both research science and creating a paperless clinical data management system. Mr. de Vries holds a B.S. in molecular biology and genetics from Carnegie Mellon University.
- Carlos Dominguez
-
Carlos Dominguez,2020年至2022年在Sprinklr Inc.担任Vice Chairman of the Board和首席布道员,在塑造公司在客户体验管理空间的愿景和战略方面发挥了关键作用。在此之前,他于2015年至2020年担任Sprinklr总裁,在发展的关键阶段监督公司运营并推动增长。他还在2015年至2018年期间担任首席运营官一职,负责优化运营并确保战略举措的有效执行。在担任Sprinklr富有影响力的职务之前,Carlos在思科公司工作了二十多年,在那里他担任过各种高级领导职务。从2008年到2015年,他在董事长兼首席执行官办公室担任高级副总裁,在那里他为影响公司方向的高级别战略决策做出了贡献。在担任这一职务之前,他曾于2004年至2008年担任全球服务提供商运营高级副总裁,专注于扩大思科在服务提供商市场的足迹。
Carlos Dominguez,served as Vice Chairman of the Board and Lead Evangelist at Sprinklr Inc. from 2020 to 2022, where he played a pivotal role in shaping the company's vision and strategy in the customer experience management space. Prior to that, he was the President of Sprinklr from 2015 to 2020, overseeing the company's operations and driving growth during a critical phase of development. He also held the position of Chief Operating Officer from 2015 to 2018, where he was responsible for optimizing operations and ensuring effective execution of strategic initiatives.Before his impactful tenure at Sprinklr, Carlos spent over two decades at Cisco Systems, Inc., where he held various senior leadership roles. From 2008 to 2015, he was Senior Vice President in the Office of the Chairman and Chief Executive Officer, where he contributed to high-level strategic decisions impacting the company's direction. Prior to this role, he served as Senior Vice President of Worldwide Service Provider Operations from 2004 to 2008, focusing on expanding Cisco's footprint in the service provider market. - Carlos Dominguez,2020年至2022年在Sprinklr Inc.担任Vice Chairman of the Board和首席布道员,在塑造公司在客户体验管理空间的愿景和战略方面发挥了关键作用。在此之前,他于2015年至2020年担任Sprinklr总裁,在发展的关键阶段监督公司运营并推动增长。他还在2015年至2018年期间担任首席运营官一职,负责优化运营并确保战略举措的有效执行。在担任Sprinklr富有影响力的职务之前,Carlos在思科公司工作了二十多年,在那里他担任过各种高级领导职务。从2008年到2015年,他在董事长兼首席执行官办公室担任高级副总裁,在那里他为影响公司方向的高级别战略决策做出了贡献。在担任这一职务之前,他曾于2004年至2008年担任全球服务提供商运营高级副总裁,专注于扩大思科在服务提供商市场的足迹。
- Carlos Dominguez,served as Vice Chairman of the Board and Lead Evangelist at Sprinklr Inc. from 2020 to 2022, where he played a pivotal role in shaping the company's vision and strategy in the customer experience management space. Prior to that, he was the President of Sprinklr from 2015 to 2020, overseeing the company's operations and driving growth during a critical phase of development. He also held the position of Chief Operating Officer from 2015 to 2018, where he was responsible for optimizing operations and ensuring effective execution of strategic initiatives.Before his impactful tenure at Sprinklr, Carlos spent over two decades at Cisco Systems, Inc., where he held various senior leadership roles. From 2008 to 2015, he was Senior Vice President in the Office of the Chairman and Chief Executive Officer, where he contributed to high-level strategic decisions impacting the company's direction. Prior to this role, he served as Senior Vice President of Worldwide Service Provider Operations from 2004 to 2008, focusing on expanding Cisco's footprint in the service provider market.
- Neil M. Kurtz
-
Neil M. Kurtz ,医学博士,从2008年8月开始,担任Golden Living公司总裁和首席执行官,这是一家私人的熟练护理、临终关怀、家庭医疗保健机构和制药公司。在加入Golden Living公司之前,从2002年开始,他担任TorreyPines Therapeutics公司总裁、首席执行官和董事,这是一家临床生物制药公司。他参与成立Worldwide Clinical Trials公司,这是一家合同研究组织,他在该公司担任总裁、首席执行官直到该公司1999年被United Health Group公司或者UHG公司收购。在收购之后,他成为Ingenix制药服务公司(Ingenix Pharmaceutical Services)总裁,这是UHG公司的一个分部,在加入TorreyPines Therapeutics公司之前,他也担任UHG公司执行委员会委员。他的职业生涯包括Boots Pharmaceuticals公司、Bayer 公司、Bristol-Myers Squibb公司和Merck公司高级职位。目前,他在Team健康控股公司(Team Health Holdings Inc.)担任董事,这是一家医院的外包医生资源方案领先的供应商;也在Golden Gate National Senior Care Holdings公司担任董事,之前还在NeurogesX公司担任董事,这是一家专业制药公司。他在纽约大学(New York University)得到心理学学士学位,在威斯康辛医学院(the Medical College of Wisconsin)得到法律博士学位。
Neil M. Kurtz, M.D. has served as president and chief executive officer of Golden Living, LLC, a privately held skilled nursing, hospice, home healthcare and institutional pharmacy company, since August 2008. Prior to joining Golden Living, Dr. Kurtz served as president and chief executive officer and a member of the board of directors of TorreyPines Therapeutics, Inc., a clinical-stage biopharmaceutical company, since 2002. Dr. Kurtz co-founded Worldwide Clinical Trials, a contract research organization, where he held the positions of president and chief executive officer until its acquisition by United Health Group, or UHG, in 1999. After the acquisition, Dr. Kurtz became president of Ingenix Pharmaceutical Services, a division of UHG, and also served as a member of the UHG Executive Board until joining TorreyPines Therapeutics, Inc. Dr. Kurtz’s career includes senior positions with Boots Pharmaceuticals, Bayer Corporation, Bristol-Myers Squibb and Merck. He currently serves on the board of directors of Team Health Holdings Inc., a leading provider of outsourced physician staffing solutions for hospitals, and Golden Gate National Senior Care Holdings, and served previously on the board of directors of NeurogesX, Inc., a specialty pharmaceutical company. Dr. Kurtz holds a B.A. in psychology from New York University and an M.D. from the Medical College of Wisconsin. - Neil M. Kurtz ,医学博士,从2008年8月开始,担任Golden Living公司总裁和首席执行官,这是一家私人的熟练护理、临终关怀、家庭医疗保健机构和制药公司。在加入Golden Living公司之前,从2002年开始,他担任TorreyPines Therapeutics公司总裁、首席执行官和董事,这是一家临床生物制药公司。他参与成立Worldwide Clinical Trials公司,这是一家合同研究组织,他在该公司担任总裁、首席执行官直到该公司1999年被United Health Group公司或者UHG公司收购。在收购之后,他成为Ingenix制药服务公司(Ingenix Pharmaceutical Services)总裁,这是UHG公司的一个分部,在加入TorreyPines Therapeutics公司之前,他也担任UHG公司执行委员会委员。他的职业生涯包括Boots Pharmaceuticals公司、Bayer 公司、Bristol-Myers Squibb公司和Merck公司高级职位。目前,他在Team健康控股公司(Team Health Holdings Inc.)担任董事,这是一家医院的外包医生资源方案领先的供应商;也在Golden Gate National Senior Care Holdings公司担任董事,之前还在NeurogesX公司担任董事,这是一家专业制药公司。他在纽约大学(New York University)得到心理学学士学位,在威斯康辛医学院(the Medical College of Wisconsin)得到法律博士学位。
- Neil M. Kurtz, M.D. has served as president and chief executive officer of Golden Living, LLC, a privately held skilled nursing, hospice, home healthcare and institutional pharmacy company, since August 2008. Prior to joining Golden Living, Dr. Kurtz served as president and chief executive officer and a member of the board of directors of TorreyPines Therapeutics, Inc., a clinical-stage biopharmaceutical company, since 2002. Dr. Kurtz co-founded Worldwide Clinical Trials, a contract research organization, where he held the positions of president and chief executive officer until its acquisition by United Health Group, or UHG, in 1999. After the acquisition, Dr. Kurtz became president of Ingenix Pharmaceutical Services, a division of UHG, and also served as a member of the UHG Executive Board until joining TorreyPines Therapeutics, Inc. Dr. Kurtz’s career includes senior positions with Boots Pharmaceuticals, Bayer Corporation, Bristol-Myers Squibb and Merck. He currently serves on the board of directors of Team Health Holdings Inc., a leading provider of outsourced physician staffing solutions for hospitals, and Golden Gate National Senior Care Holdings, and served previously on the board of directors of NeurogesX, Inc., a specialty pharmaceutical company. Dr. Kurtz holds a B.A. in psychology from New York University and an M.D. from the Medical College of Wisconsin.
- George W. McCulloch
-
George W. McCulloch,目前是Level Equity Management公司合伙人,这是一家2009年7月,他参与创立的私人投资公司。之前,2003年1月,他加入Insight风险合伙公司(Insight Venture Partners)并在该公司担任常务董事。他在斯坦福大学(Stanford University)得到历史学学士学位。
George W. McCulloch is currently a partner at Level Equity Management, LLC, a private investment firm he co-founded in 2009. Previously Mr. McCulloch served as a managing director at Insight Venture Partners, which he joined in 2003. Mr. McCulloch holds a B.A. in history from Stanford University. - George W. McCulloch,目前是Level Equity Management公司合伙人,这是一家2009年7月,他参与创立的私人投资公司。之前,2003年1月,他加入Insight风险合伙公司(Insight Venture Partners)并在该公司担任常务董事。他在斯坦福大学(Stanford University)得到历史学学士学位。
- George W. McCulloch is currently a partner at Level Equity Management, LLC, a private investment firm he co-founded in 2009. Previously Mr. McCulloch served as a managing director at Insight Venture Partners, which he joined in 2003. Mr. McCulloch holds a B.A. in history from Stanford University.
- Robert B. Taylor
-
Robert B. Taylor,从2001年1月开始他担任The Colonial Williamsburg基金会财务和行政高级副总裁。在加入The Colonial Williamsburg基金会之前,从1985年到2001年,他在卫斯理大学(Wesleyan University)担任副总裁和司库。之前,从1988年到2013年,他也在Zygo 公司担任董事,包括该公司治理与提名委员会主席和审计委员会主席。他在圣劳伦斯大学(St. Lawrence University)得到学士学位。
Robert B. Taylor, currently our lead director, served as senior vice president for finance and administration of The Colonial Williamsburg Foundation from January 2001 to December 2014. Prior to joining The Colonial Williamsburg Foundation, Mr. Taylor previously served as vice president and treasurer of Wesleyan University from 1985 to 2001. Mr. Taylor also previously served on the board of directors of Zygo Corporation from 1988 to 2013 including as a member of its corporate governance/nominating committee and chairman of its audit committee. Mr. Taylor holds a B.A. from St. Lawrence University. - Robert B. Taylor,从2001年1月开始他担任The Colonial Williamsburg基金会财务和行政高级副总裁。在加入The Colonial Williamsburg基金会之前,从1985年到2001年,他在卫斯理大学(Wesleyan University)担任副总裁和司库。之前,从1988年到2013年,他也在Zygo 公司担任董事,包括该公司治理与提名委员会主席和审计委员会主席。他在圣劳伦斯大学(St. Lawrence University)得到学士学位。
- Robert B. Taylor, currently our lead director, served as senior vice president for finance and administration of The Colonial Williamsburg Foundation from January 2001 to December 2014. Prior to joining The Colonial Williamsburg Foundation, Mr. Taylor previously served as vice president and treasurer of Wesleyan University from 1985 to 2001. Mr. Taylor also previously served on the board of directors of Zygo Corporation from 1988 to 2013 including as a member of its corporate governance/nominating committee and chairman of its audit committee. Mr. Taylor holds a B.A. from St. Lawrence University.
高管简历
中英对照 |  中文 |  英文- Mary Weger
Mary Weger,2014年10月以来,她一直担任我们的首席绩效官。从2011年12月到2014年10月,她担任我们的高级副总裁,负责人力资源。加入公司之前,她曾担任Celgene Corporation的高级副总裁,负责全球临床发展战略和有效性(2010年10月以来)。此前,她曾担任Celgene公司的高级副总裁,负责全球人力资源(从2002年5月到2010年10月),在那里她曾帮助建立全球Celgene公司,并协助公司从一个150多员工的公司转变到一个收入超过40亿美元的全球组织,涉及30多个国家。加入Celgene公司之前,她曾担任Kraft Foods Nabisco公司的职务,并不断被提拔。她于2011年获得Villanova University的硕士证书,以及六西格玛黑带。她也持有人力资源管理硕士学位,并完成Michigan University的行政人力资源课程。她目前任职于Family Promise(一个非盈利组织,解决无家可归的人的需要)的董事会。
Mary Weger has served as our executive vice president-human resources since February 2017. Prior to joining us, Ms. Weger served as the interim chief human resource officer for Synergy Pharmaceuticals from July 2016 to February 2017 and concurrently as an executive human resources consultant at Edge Therapeutics, Inc. Prior to that, she served at Aegerion Pharmaceuticals from December 2011 to January 2016 first as senior vice president, human resources, and then as chief performance officer. Ms. Weger joined Celgene in 2001 and was instrumental in its global growth as SVP, global human resources, while also supporting Clinical Development Strategy and Effectiveness. She has also held senior human resource positions at Nabisco. Ms. Weger holds a M.A. in human resource management from Fairleigh Dickinson University, a Masters Certificate and Six Sigma Black Belt from Villanova University, and a B.S. in business administration from Fairleigh Dickinson University.- Mary Weger,2014年10月以来,她一直担任我们的首席绩效官。从2011年12月到2014年10月,她担任我们的高级副总裁,负责人力资源。加入公司之前,她曾担任Celgene Corporation的高级副总裁,负责全球临床发展战略和有效性(2010年10月以来)。此前,她曾担任Celgene公司的高级副总裁,负责全球人力资源(从2002年5月到2010年10月),在那里她曾帮助建立全球Celgene公司,并协助公司从一个150多员工的公司转变到一个收入超过40亿美元的全球组织,涉及30多个国家。加入Celgene公司之前,她曾担任Kraft Foods Nabisco公司的职务,并不断被提拔。她于2011年获得Villanova University的硕士证书,以及六西格玛黑带。她也持有人力资源管理硕士学位,并完成Michigan University的行政人力资源课程。她目前任职于Family Promise(一个非盈利组织,解决无家可归的人的需要)的董事会。
- Mary Weger has served as our executive vice president-human resources since February 2017. Prior to joining us, Ms. Weger served as the interim chief human resource officer for Synergy Pharmaceuticals from July 2016 to February 2017 and concurrently as an executive human resources consultant at Edge Therapeutics, Inc. Prior to that, she served at Aegerion Pharmaceuticals from December 2011 to January 2016 first as senior vice president, human resources, and then as chief performance officer. Ms. Weger joined Celgene in 2001 and was instrumental in its global growth as SVP, global human resources, while also supporting Clinical Development Strategy and Effectiveness. She has also held senior human resource positions at Nabisco. Ms. Weger holds a M.A. in human resource management from Fairleigh Dickinson University, a Masters Certificate and Six Sigma Black Belt from Villanova University, and a B.S. in business administration from Fairleigh Dickinson University.
- Rouven Bergmann
Rouven Bergmann,他于2015年5月加入我们,担任我们的首席财务官。加入公司之前,他曾担任SAP的多种领导职务,最近担任SAP North America的首席财务官(2014年3月至2015年4月)。他此前曾担任SAP的全球研发组织的首席运营官(2012年至2014年)、SAP的技术、创新和云部门的首席财务官(2010年至2012年)、SAP的业务对象部门的首席财务官(2008年至2010年)、SAP India的首席财务官(2007年至2008年)、SAP的公司财务规划和分析主管(2005年至2007年)。他持有Technical University of Kaiserslautern(位于德国)的机械工程和工商管理硕士学位,以及the University of Munich(位于德国)的经济学和财务博士学位。
Rouven Bergmann joined us as our chief financial officer in May 2015. Prior to joining the company, Mr. Bergmann worked in various leadership positions at SAP, most recently serving as chief financial officer of SAP North America from March 2014 to April 2015. Mr. Bergmann previously served as chief operating officer for SAP's global R&D organization 2012-2014 chief financial officer for SAP's technology, innovation and cloud division (2010-2012), chief financial officer for SAP's Business Objects division (2008-2010), chief financial officer for SAP India (2007-2008) and led SAP's corporate financial planning & analysis process (2005-2007). Mr. Bergmann earned masters degrees in mechanical engineering and business administration from Technical University of Kaiserslautern in Germany and a PhD in economics and finance from the University of Munich in Germany.- Rouven Bergmann,他于2015年5月加入我们,担任我们的首席财务官。加入公司之前,他曾担任SAP的多种领导职务,最近担任SAP North America的首席财务官(2014年3月至2015年4月)。他此前曾担任SAP的全球研发组织的首席运营官(2012年至2014年)、SAP的技术、创新和云部门的首席财务官(2010年至2012年)、SAP的业务对象部门的首席财务官(2008年至2010年)、SAP India的首席财务官(2007年至2008年)、SAP的公司财务规划和分析主管(2005年至2007年)。他持有Technical University of Kaiserslautern(位于德国)的机械工程和工商管理硕士学位,以及the University of Munich(位于德国)的经济学和财务博士学位。
- Rouven Bergmann joined us as our chief financial officer in May 2015. Prior to joining the company, Mr. Bergmann worked in various leadership positions at SAP, most recently serving as chief financial officer of SAP North America from March 2014 to April 2015. Mr. Bergmann previously served as chief operating officer for SAP's global R&D organization 2012-2014 chief financial officer for SAP's technology, innovation and cloud division (2010-2012), chief financial officer for SAP's Business Objects division (2008-2010), chief financial officer for SAP India (2007-2008) and led SAP's corporate financial planning & analysis process (2005-2007). Mr. Bergmann earned masters degrees in mechanical engineering and business administration from Technical University of Kaiserslautern in Germany and a PhD in economics and finance from the University of Munich in Germany.
- Michael Pray
Michael Pray自2016年10月起担任我们的执行Vice President-全球销售总经理。加入我们之前,他曾担任Tangoe公司的首席营收官(2015年7月至2016年10月),在那里他负责收入、需求生成、新业务开发、联盟、客户保留和整体上市战略。在此之前,Pray先生在IBM工作了14年,担任过多个执行职位,包括IBM分析解决方案销售Vice President和IBM Software Group企业内容管理销售Vice President。Pray先生在密歇根大学(University of Michigan)获得学士学位。
Michael Pray has served as our executive vice president-general manager of global sales since October 2016. Prior to joining us, Mr. Pray served as chief revenue officer of Tangoe from July 2015 to October 2016 where he was responsible for revenue, demand generation, new business development, alliances,client retention, and overall go-to-market strategy. Prior to that, Mr. Pray spent 14 years at IBM where he held several executive positions, including vice president of IBM Analytic Solution Sales, and vice president of Enterprise Content Management Sales for IBM Software Group. Mr. Pray earned a Bachelor’s degree from the University of Michigan.- Michael Pray自2016年10月起担任我们的执行Vice President-全球销售总经理。加入我们之前,他曾担任Tangoe公司的首席营收官(2015年7月至2016年10月),在那里他负责收入、需求生成、新业务开发、联盟、客户保留和整体上市战略。在此之前,Pray先生在IBM工作了14年,担任过多个执行职位,包括IBM分析解决方案销售Vice President和IBM Software Group企业内容管理销售Vice President。Pray先生在密歇根大学(University of Michigan)获得学士学位。
- Michael Pray has served as our executive vice president-general manager of global sales since October 2016. Prior to joining us, Mr. Pray served as chief revenue officer of Tangoe from July 2015 to October 2016 where he was responsible for revenue, demand generation, new business development, alliances,client retention, and overall go-to-market strategy. Prior to that, Mr. Pray spent 14 years at IBM where he held several executive positions, including vice president of IBM Analytic Solution Sales, and vice president of Enterprise Content Management Sales for IBM Software Group. Mr. Pray earned a Bachelor’s degree from the University of Michigan.
- Michael L. Capone
Michael L. Capone于1988加入ADP公司。在他于2008年升值为副总裁和首席信息官之前,自2005年至2008年他担任高级副总裁和全球视角部门的总经理职位。
Michael L. Capone joined us as our chief operating officer in October 2014Prior to joining Medidata, Mr. Capone worked in various executive positions at Automatic Data Processing, Inc. “ADP”, serving as corporate vice president of product development and chief information officer of ADP (from July 2008 to September 2014), and senior vice president and general manager of ADP’s Global HR/Payroll Outsourcing Business (from July 2005 to June 2008). Mr. Capone holds a B.S. in Computer Science from Dickinson College and an M.B.A. in finance from Pace University.- Michael L. Capone于1988加入ADP公司。在他于2008年升值为副总裁和首席信息官之前,自2005年至2008年他担任高级副总裁和全球视角部门的总经理职位。
- Michael L. Capone joined us as our chief operating officer in October 2014Prior to joining Medidata, Mr. Capone worked in various executive positions at Automatic Data Processing, Inc. “ADP”, serving as corporate vice president of product development and chief information officer of ADP (from July 2008 to September 2014), and senior vice president and general manager of ADP’s Global HR/Payroll Outsourcing Business (from July 2005 to June 2008). Mr. Capone holds a B.S. in Computer Science from Dickinson College and an M.B.A. in finance from Pace University.
- Tarek A. Sherif
Tarek A. Sherif,是公司创立者之一。从2001年开始,他担任首席执行官,从2000年开始他担任公司董事。在成立Medidata 公司之前,他是Sherif Partners 公司管理人员,这是一家专注于科技和生命科学公司公开或私募投资的公司。在那之前,他在R.D.L. Securities公司担任投资组合经理,这是一家私人股本基金公司,主要专注于上市公司,包括哪些健康保健和信息科技领域的公司。他也在通用电气资本公司(General Electric Capital Corporation)担任财务助理副总裁,在Brown Brothers Harriman & Company公司担任合并和收购分析师。他在耶鲁大学(Yale College)得到经济学学士学位,在哥伦比亚大学(Columbia University)得到企业行政和财务工商管理硕士学位。
Tarek A. Sherif is one of our founders. Mr. Sherif has served as our chief executive officer since 2001 and as a member of our board of directors since 2000. Prior to forming Medidata, Mr. Sherif co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance. Mr. Sherif holds a B.A. in economics from Yale College and an M.B.A. in business administration and finance from Columbia University.- Tarek A. Sherif,是公司创立者之一。从2001年开始,他担任首席执行官,从2000年开始他担任公司董事。在成立Medidata 公司之前,他是Sherif Partners 公司管理人员,这是一家专注于科技和生命科学公司公开或私募投资的公司。在那之前,他在R.D.L. Securities公司担任投资组合经理,这是一家私人股本基金公司,主要专注于上市公司,包括哪些健康保健和信息科技领域的公司。他也在通用电气资本公司(General Electric Capital Corporation)担任财务助理副总裁,在Brown Brothers Harriman & Company公司担任合并和收购分析师。他在耶鲁大学(Yale College)得到经济学学士学位,在哥伦比亚大学(Columbia University)得到企业行政和财务工商管理硕士学位。
- Tarek A. Sherif is one of our founders. Mr. Sherif has served as our chief executive officer since 2001 and as a member of our board of directors since 2000. Prior to forming Medidata, Mr. Sherif co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance. Mr. Sherif holds a B.A. in economics from Yale College and an M.B.A. in business administration and finance from Columbia University.
- Glen M. de Vries
Glen M. de Vries ,是公司创立者之一。从2008年2月开始,他担任公司总裁,从1999年开始,他担任公司董事。从2000年到2008年,他担任公司首席科技官。他在医疗软件开发方面有超过15年的经验,包括电子健康记录和以消费者为导向的产品方面。作为OceanTek公司的总裁,这是一家专注于健康保健业应用的网络开发公司,他是全球财富500强电子商务项目首席咨询师,目前也是网站和企业内部网使用的网络安全组件的制作者。之前,他在哥伦比亚大学(Columbia University)担任研究助理,专注于研究科学和创造无纸化临床数据管理系统。他在卡内基梅隆大学(Carnegie Mellon University)得到分子生物学和遗传学学士学位。
Glen M. de Vriesis one of our founders. Mr. de Vries has served as our president since February 2008 and as a member of our board of directors since 1999. From 2000 to 2008 Mr. de Vries served as our chief technology officer. Mr. de Vries has over 20 years of experience in medical software development, including electronic health records and consumer-targeted products. Previously, he served as a research assistant at Columbia University focusing on both research science and creating a paperless clinical data management system. Mr. de Vries holds a B.S. in molecular biology and genetics from Carnegie Mellon University.- Glen M. de Vries ,是公司创立者之一。从2008年2月开始,他担任公司总裁,从1999年开始,他担任公司董事。从2000年到2008年,他担任公司首席科技官。他在医疗软件开发方面有超过15年的经验,包括电子健康记录和以消费者为导向的产品方面。作为OceanTek公司的总裁,这是一家专注于健康保健业应用的网络开发公司,他是全球财富500强电子商务项目首席咨询师,目前也是网站和企业内部网使用的网络安全组件的制作者。之前,他在哥伦比亚大学(Columbia University)担任研究助理,专注于研究科学和创造无纸化临床数据管理系统。他在卡内基梅隆大学(Carnegie Mellon University)得到分子生物学和遗传学学士学位。
- Glen M. de Vriesis one of our founders. Mr. de Vries has served as our president since February 2008 and as a member of our board of directors since 1999. From 2000 to 2008 Mr. de Vries served as our chief technology officer. Mr. de Vries has over 20 years of experience in medical software development, including electronic health records and consumer-targeted products. Previously, he served as a research assistant at Columbia University focusing on both research science and creating a paperless clinical data management system. Mr. de Vries holds a B.S. in molecular biology and genetics from Carnegie Mellon University.
- Michael I. Otner
Michael I. Otner,从2007年11月开始担任公司总经理和秘书长,2013年2月被提升为执行副总裁。在加入我们公司之前,从2005年到2007年,他担任The BISYS Group公司副总经理、副总裁和副秘书长,在那里他负责SEC 和一般的公司事务,还有该公司私人股本服务公司的法律支持事务。之前,他在GlobespanVirata公司和Conexant Systems公司担任责任日益增长的律师的职务,包括在两家公司担任总法律顾问。之前,他在Olshan公司和证券法律事务方面开始他的法律职业生涯,Olshan Grundman Frome Rosenzweig & Wolosky公司是位于纽约的律师事务所。他在凯斯西储大学(Case Western Reserve University School of Law)得到法律博士学位,在威斯康辛麦迪逊大学(the University of Wisconsin-Madison)得到市场营销学士学位。
Michael I. Otner has served as our general counsel and corporate secretary since November 2007 and was promoted to executive vice president in February 2013. Prior to joining us, Mr. Otner served as associate general counsel, vice president and assistant secretary of The BISYS Group, Inc. from 2005 to 2007 where he was responsible for a broad range of SEC and general corporate matters, as well as legal support for the company’s private equity services business. Mr. Otner previously held various counsel roles of increasing responsibility at GlobespanVirata, Inc. and Conexant Systems, Inc., including serving as general counsel at both companies. Mr. Otner began his legal career specializing in corporate and securities law at Olshan formerly, Olshan Grundman Frome Rosenzweig & Wolosky LLP, a law firm based in New York City. Mr. Otner holds a J.D. from Case Western Reserve University School of Law and a B.B.A. in marketing from the University of Wisconsin-Madison.- Michael I. Otner,从2007年11月开始担任公司总经理和秘书长,2013年2月被提升为执行副总裁。在加入我们公司之前,从2005年到2007年,他担任The BISYS Group公司副总经理、副总裁和副秘书长,在那里他负责SEC 和一般的公司事务,还有该公司私人股本服务公司的法律支持事务。之前,他在GlobespanVirata公司和Conexant Systems公司担任责任日益增长的律师的职务,包括在两家公司担任总法律顾问。之前,他在Olshan公司和证券法律事务方面开始他的法律职业生涯,Olshan Grundman Frome Rosenzweig & Wolosky公司是位于纽约的律师事务所。他在凯斯西储大学(Case Western Reserve University School of Law)得到法律博士学位,在威斯康辛麦迪逊大学(the University of Wisconsin-Madison)得到市场营销学士学位。
- Michael I. Otner has served as our general counsel and corporate secretary since November 2007 and was promoted to executive vice president in February 2013. Prior to joining us, Mr. Otner served as associate general counsel, vice president and assistant secretary of The BISYS Group, Inc. from 2005 to 2007 where he was responsible for a broad range of SEC and general corporate matters, as well as legal support for the company’s private equity services business. Mr. Otner previously held various counsel roles of increasing responsibility at GlobespanVirata, Inc. and Conexant Systems, Inc., including serving as general counsel at both companies. Mr. Otner began his legal career specializing in corporate and securities law at Olshan formerly, Olshan Grundman Frome Rosenzweig & Wolosky LLP, a law firm based in New York City. Mr. Otner holds a J.D. from Case Western Reserve University School of Law and a B.B.A. in marketing from the University of Wisconsin-Madison.